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1083-8791/ 2015 American Sociea b s t r a c t
The National Marrow Donor Program’s Be The Match Registry facilitates the worldwide utilization of un-
related donor (URD) grafts for patients in need of a hematopoietic cell transplantation. In this study, we
estimate the URD match rate for patients of White (WH), Hispanic (HIS), Asian/Paciﬁc Islander (API), and
African American/Black (AFA) race and ethnic groups. We chose 1344 URD at random as “pseudo-patients”
(PP) to estimate the likelihood of ﬁnding an 8/8 or 10/10 high-resolution HLA-A,-B,-C,-DRB1 (and -DQB1)
matched URD. Searches were conducted in the Be The Match Registry database for each PP at 2 time points:
2009 and 2012. URD who were a potential match for a PP by low/intermediate resolution were HLA typed by
sequence-based typing to resolve the matching status. The 8/8 match rate for WH PP improved from 68% in
2009 to 72% in 2012. Corresponding match rates were 41% to 44% for HIS, 44% to 46% for API, and 27% to 30%
for AFA, for 2009 and 2012, respectively. The 2012 10/10 match rates were 67% for WH, 38% for HIS, 41% for
API, and 23% for AFA. These results provide baseline 8/8 and 10/10 match rate estimates by race for patients
seeking an URD.
 2015 American Society for Blood and Marrow Transplantation.INTRODUCTION
Allogeneic hematopoietic cell transplantation is a therapy
for malignant and nonmalignant blood disorders. The Na-
tional Marrow Donor Program’s (NMDP) Be The Match
Registry has facilitated over 61,000 unrelated donor (URD)
transplantations since its inception in 1987. Human leuko-
cyte antigen (HLA) matching between the URD and the pa-
tient is important for transplantation success, reducing
treatment-related mortality and graft-versus-host disease,
and improving overall survival [1-4]. High-resolution (HR)
matching at 4 loci (8 alleles) HLA-A, -B, -C, and -DRB1 pro-
vides superior outcomes compared with transplantations
having 1 or more mismatches [2]. Although transplantation
is performed on behalf of individuals of all race and ethnicdgments on page 140.
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ty for Blood and Marrow Transplantation.(hereafter “race”) groups, disparities exist in the percentage
of patients achieving transplantation with a suitable URD, as
well as in the quality of HLA match of those URD available to
the patient [5,6].
Previous studies have estimated the HLA match rate of
patients based on modeling simulations using population
genetics frequencies [7-10]. Although modeling approaches
are statistically sound, they rely on a number of simplifying
assumptions and approximations. Furthermore, the clinical
goal for HLAmatching (4 loci, HR) is higher than the majority
of the URD typing in the registry (3 loci, intermediate reso-
lution). Although patients registering through the NMDP
would seem like a logical cohort to study, selection bias
confounds the group because of patient access of care, in-
surance barriers, referral patterns, and socioeconomic fac-
tors. In addition, resources of time and money often prevent
complete typing of all potential 8/8 URD matches on actual
patient searches before moving forward with a 7/8 or lesser
match. Therefore, we ran mock URD searches on randomly
selected donors listed on the Be The Match Registry serving
as “pseudo-patients” (PP) to avoid these potential sources of
Figure 1. 2009 registry. Pre (initial search results) and post (after donor HLA
typing) typing 8/8 HR match rate by race. Indeterminate in “pre” typing col-
umns is deﬁned as PP with potential URD to match at 8/8 but further typing is
required. Indeterminate in “post” typing columns is deﬁned as PP without a
deﬁned 8/8 match and additional URD remain untested. WH indicates White;
HIS, Hispanic; API, Asian/Paciﬁc Islander; AFA, African American/Black.
J. Dehn et al. / Biol Blood Marrow Transplant 21 (2015) 137e141138bias. Combined with centralized URD selection and HLA
typing, this approach provided a better controlled estimate
of the actual likelihood of ﬁnding a matched URD than
clinical searches.
This study estimates the 8/8 HLA-A, -B, -C, and -DRB1 and
10/10 (with HLA-DQB1) HR match rate for patients from the
4 most populous US race categoriesdWhite (WH), Hispanic
(HIS), Asian/Paciﬁc Islander (API), and African American/
Black (AFA) [11]. Historically, in NMDP patient populations,
AFA have the lowest proportion of 8/8 HLA-matched trans-
plantations, whereas WH have the highest.
In the practice of URD selection, transplantation centers
navigate the process of selecting URD while balancing pro-
tocols and treatment of the patient’s disease. Although cen-
ters look for adult URD who match at 8/8, and often 10/10,
alternatives to this include 7/8 mismatched URD and um-
bilical cord blood transplantations [12]. Knowledge of the 8/8
match rate of various populations can help patients and
transplantation centers understand the likelihood and
typical experience of search outcomes to facilitate a con-
versation with patients about the search strategy and po-
tential for alternative treatment options early in the process
should no fully HLA-matched available donor be found.
METHODS
PP Population
Previous randomly selected NMDP volunteers, registered as potential
URDs on the Be The Match Registry, were typed at HR HLA-A, -B, -C, -DRB1,
and -DQB1. Selection of the non-WH URD populations (ie, HIS, API, AFA) and
HLA typing were previously reported [13], and a more recent set of random
WHURDwere typed using a similar process (NMDP unpublished data). URD
race is self-reported at the time of donor registration into the registry. This
random group of URD presented a cohort of HLA genotypes that were
sampled and used as PP to run URD searches using a static NMDP registry
ﬁle from January 2009 that contained 6 million HLA-A, -B, -DRB1etyped
URD with a composition of 68% WH, 10% HIS, 7% API, 8% AFA, and 6% re-
ported as unknown, declined, other, or multiple race. URD typed at only
HLA-A and -B (ie, no HLA-DRB1) on the registry were not included in this
study.
The initial PP URD search yields 1 of 3 outcomes: (1) 8/8 HR URD match
identiﬁed, (2) no possibility of an 8/8 HR URD, or (3) URD has potential to
match at 8/8 but further typing is required. PP cases in outcome category 3
were accrued until 200 were studied in each race group resulting in total
populations (categories 1 to 3 combined) of WH¼ 377, HIS¼ 307, API¼ 270,
and AFA ¼ 390.
PP search results were computed using the HapLogic matching algo-
rithm and viewed in the NMDPs internal SearchLink software. A second
phase of the project using a static NMDP registry ﬁle from January 2012
updated the same PP cases for changes in the 8/8 match rate and to establish
a 10/10 match rate. The 2012 ﬁle represents 3 years of URD ﬁle growth
(w43% increase) to a total ﬁle size of 8.6 million HLA-A, -B, -DRB1etyped
URD. The institutional review board of the NMDP approved this study.
HR Match Deﬁnition
PP with at least 1 potential 8/8 match were evaluated for identiﬁcation
of URDsmeeting the deﬁnition of HRmatch. HRmatch was deﬁned as any of
the following: (1) an allele match, (2) an allele match within the exons
encoding the antigen recognition site, or (3) an allele match when
restricting to genotypes containing alleles on the common and well-
documented HLA allele list [14].
HLA Typing
An NMDP HLA specialist evaluated each search, ranked potential 8/8
URD in order of likelihood of match, and identiﬁed per locus typing required
to achieve the HR match deﬁnition. URD samples were typed in order of
rank for each PP, until an HLA match was found, no further potential match
existed, or only URDs without an available sample for typing remained
(referred to as “indeterminate” in post-HLAetyped PP). The majority of URD
typed for this study were from NMDP donor centers, including the US C.W.
Bill Young Department of Defense Marrow Donor Program, and the German
and US DKMS donor centers. The German DKMS donor center obtained new
samples fromwilling URD when a stored sample was not accessible. Several
other URD registries also participated, including the Caitlin RaymondInternational Registry (United States), Europdonor Foundation
(Netherlands), Gift of Life Bone Marrow Foundation (United States),
Hadassah Bone Marrow Donor Registry (Israel), Knochenmarkspenderzen-
trale Dusseldorf (Germany), and The Tobias Registry (Sweden).
NMDP and URD samples from the other participating registries,
excluding the German DKMS, were typed by HR sequence-based typing
techniques at HistoGenetics, LLC. German DKMS samples were typed at the
DKMS Life Science Lab using sequence-based typing. Both laboratories are
American Society for Histocompatibility and Immunogeneticseaccredited
and URD typing included blind quality control samples to ensure accuracy of
typing and reporting.
Statistical Analysis
Univariate logistic regression testing the association of race group on the
likelihood of ﬁnding an 8/8-matched URD (post-HLA typing activities) was
performed. P values of < .05 were used to determine statistical signiﬁcance.
The dependent variable included the binary categories 8/8 HRmatch and no
8/8 HR match. No 8/8 HR match was deﬁned as all searches where no 8/8
URD was found plus indeterminate cases (ie, only URD without testable
samples remained).
RESULTS
Figure 1 shows the 2009 8/8 HR match rate in a side-by-
side view for each race group, before and after donor typing.
This depicts the experience of the PP at initial URD search
results and the outcome after HLA typing of potentially
matching URD. The post-typing 8/8 URD match rate for WH
was 68%; HIS, 41%; API, 44%; and AFA, 27%. All race groups
demonstrated a dramatic increase in match rate based on the
HLA typing of URD to achieve the HR match deﬁnition.
Figure 2A to D displays the experience of URD HLA typing
and match outcome by PP race using the year 2009 registry.
Eighty-seven percent of WH PP who identiﬁed an 8/8 match
via URD HLA typing (n ¼ 118) required 2 or fewer URD se-
lections (median, 1; range, 1 to 132), contrasted with PP who
did not identify a HRmatch after URD typing (n¼ 82;median
3; range, 1 to 298). Ninety-eight percent of HIS PP where a
match was found via HLA typing (n¼ 91) required 2 or fewer
selections to identify an 8/8 match (median, 1; range, 1 to 74)
versus PP who did not identify a match (n ¼ 109; median, 3;
range, 1 to 85), 91% of API PP (n ¼ 95) required 2 or fewer
selections (median, 1; range, 1 to 61) versus (n ¼ 105; me-
dian, 3; range, 1 to 140), and 99% of AFA PP (n ¼ 84) required
2 or fewer selections (median, 1; range, 1 to 5) versus
(n ¼ 114; median, 1; range, 1 to 61), respectively.
The second phase of the project, which looked at the 8/8
match rate of this same cohort of PP based on the 2012
Figure 2. 2009 registry. Selection of URD to identify an 8/8 match by PP race. Displays the number of typed donors out of total 8/8 potential donors (shown on log 10
scale) listed on a PP search. “No match identiﬁed after typing” includes PP cases where some URD remained untested. (A) WH: 87% of the WH PP subset with an 8/8
match identiﬁed via HLA typing (n ¼ 118) required 2 or fewer URD selections, and 94% of all WH PP identifying a match (existing and via typing; n ¼ 258) required 2
or fewer URD selections. (B) HIS: 98% of the HIS PP subset with an 8/8 match identiﬁed via HLA typing (n ¼ 91) required 2 or fewer URD selections, and 98% of all HIS
PP identifying a match (existing and via typing; n ¼ 127) required 2 or fewer URD selections. (C) API: 91% of the API PP subset with an 8/8 match identiﬁed via HLA
typing (n ¼ 93) required 2 or fewer URD selections, and 93% of all API PP identifying a match (existing and via typing; n ¼ 120) required 2 or fewer URD selections. (D)
AFA: 99% of the AFA PP subset with an 8/8 match identiﬁed via HLA typing (n ¼ 84) required 2 or fewer URD selections, and 99% of all AFA PP identifying a match
(existing and via typing; n ¼ 105) required 2 or fewer URD selections.
J. Dehn et al. / Biol Blood Marrow Transplant 21 (2015) 137e141 139database showed increases in the URD match rate (Table 1).
From 2009 to 2012, the 8/8 match rate increased from 68% to
72% forWH, 41% to 44% for HIS, 44% to 46% for API, and 27% to
30% for AFA. This represented an absolute increase of 4% for
WH and 3% for AFA resulting from an inventory increase of
27%WH and 24% AFAURD, considering new recruitment and
URD ﬁle attrition. Assessment of the 2012 10/10 match rate
resulted in 5% to 7% decrement of the match rate estimate in
each race group; 10/10match rates were 67% forWH, 38% for
HIS, 41% for API, and 23% for AFA (Figure 3), although
accompanied by higher occurrence of indeterminate PP
without URD samples available for typing.
Univariate logistic regression analysis based on the 2012
registry ﬁle (Table 2) shows the post-typing likelihood of
identifying an 8/8 HRematched URD was associated with PP
race, with WHmore likely to have an 8/8-matched URD than
HIS (odds ratio [OR], .295; P < .0001), API (OR, .324; P <
.0001), and AFA (OR, .165; P < .0001). HIS and API odds ratios
were also signiﬁcantly different from AFA, although they did
not differ from each other (results not shown).Table 1
2012 Registry of 8/8 HR Match Rate by PP Race
Match Outcome PP Race/Ethnic Group
WH HIS API AFA
8/8 match 273 (72%) 134 (44%) 124 (46%) 118 (30%)
No 8/8 match 69 (18%) 121 (39%) 98 (36%) 234 (60%)
Indeterminate; donor(s)
remain untested
35 (9%) 52 (17%) 48 (18%) 38 (10%)
Total 377 307 270 390DISCUSSION
This study provides an 8/8 and 10/10 HR match rate es-
timate for WH, HIS, API, and AFA patients searching the Be
The Match Registry, which has not been accomplished pre-
viously through empirical data. Registry results from the year
2012 database ﬁle show the impact of race on the 8/8 match
rate is pronounced, with the absolute WH rate being
approximately 25% to 40% higher than that of the other race
groups.
A previous study using population genetics modeling
predicted the likelihood of identifying a suitable URD in 21Figure 3. 2012 Registry: 10/10 HR match rate by race. Indeterminate is deﬁned
as PP without an identiﬁed 10/10 match and additional URD remain untested.
WH indicates White; HIS, Hispanic; API, Asian/Paciﬁc Islander; AFA, African
American/Black.
Table 2
2012 Likelihood of Having an 8/8 (HLA-A, -B, -C, -DRB1)eMatched Donor by
Race*
Race n OR 95% CI P Value
WH 377 1 - -
HIS 307 .295 .214-.406 <.0001
API 270 .324 .233-.450 <.0001
AFA 390 .165 .121-.226 <.0001
CI indicates conﬁdence interval.
* No match modeled as combination of No 8/8 match and Indeterminate
cases.
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ulations used in our study were at the broad race level, but
match rates were consistent with the 8/8 match rates from
the modeling studies on the speciﬁc race categories. In the
statistical-based modeling study, without consideration of
URD availability, 2 WH groups had a match rate of 53% to
81%, compared with 72% in our study. Three detailed HIS
groups had amatch rate between 44% to 52% which is similar
to the 44% in our study. Eight detailed API groups had the
range of 38% to 56%, which is consistent with the 46% in our
study. Finally, 4 detailed AFA race groups match rate ranged
from 27% to 34%, which overlaps the 30% identiﬁed for AFA in
our study.
In addition to providing empirical conﬁrmation of match
rates reported by statistical modeling, this study reveals the
fact that across all race categories, the majority (51% to 74%)
of searches have an indeterminate state before URD selec-
tion and typing. This “resolution gap” is due to changing
clinical HLA matching practices over the 25 year history of
the registry and highlights a challenge for registry devel-
opment that can be partially ﬁlled by innovations in bioin-
formatics with predictive matching algorithms and HLA
specialist consultation. However, in the long run, this will
require both strategic recruitment to increase representa-
tion of URD from race groups with lower patient match rates
and require URD recruitment HLA-typing strategies to pro-
vide typing at the resolution that clinical selections for
transplant are made.
Although matching at 8 alleles is a standard practice for
minimum URD criteria, many transplantation centers will
choose URD based on 10 allele matching. Our results showed
that the match rate does decrease in each race group with
the addition of DQB1 matching criteria, although it is
notable that some PP cases with 8/8 matches had URD
options that could not be typed because of lacking DNA
samples. Overall, because of strong HLA linkage disequilib-
rium, most of the PP matched at 8 alleles were also matched
at 10 alleles.
The likelihood that a patient will ﬁnd a well-matched
URD clearly varies by race group. This variation is due to
HLA diversity of the population as well as limited represen-
tation in the global pool of URD [15,16]. At the time of initial
search results, AFA PP often had fewer potential 8/8 URD to
pursue. A predictive matching algorithm, such as HapLogic,
can provide allele match likelihoods across the spectrum of
HLA-typing resolution to assist in URD selection by nar-
rowing the list to a few choices with a higher likelihood of
matching [12]. A physician can then consider the HLA and
non-HLA factors of prospective URD before 1 being selected
for treatment of their patient.
Our study shows that by using an HLA specialist to pro-
vide guidance in selection of URD for further testing, it is
possible for most patients to ﬁnd their matching URD afterjust 1 to 2 selections. This also reﬂects the higher level of URD
HLA typing that exists in the inventory, resulting in
increasingly better HLA characterized URD that require only
clariﬁcation of alleles to meet the deﬁnition of HR.
One limitation of this study is that we did not adjust for
the fact that a URD listed in a volunteer registry may be
unavailable when requested by a transplantation center. URD
availability continues to be a challenge for URD hematopoi-
etic cell transplantation, particularly among non-WH URD
[17]. Most of the non-WH cases had fewer potential 8/8-
matched URD, and many of the cases that did have an 8/8-
matched URD had only 1.When possible, overselection in the
number of URD for typing is suggested as best practice to
compensate for the greater percentage unavailable in non-
WH URD pools [12,17].
A second limitation is that not all URD appearing on the
search results could be HLA typed. This resulted in a con-
servative estimate of the match rate that could be slightly
increased given the ability of typing all potential URDs.
However, most of these cases already had numerous URD
typed on the behalf of that PP and based on HLA specialist
review, additional untyped URD often had no indication that
they would be any more likely to match.
In addition to the above limitations, the NMDP URD ﬁle
includes some volunteer URD who have familial relation-
ships. With conﬁdential information on each URD not
available to the search process, a small percentage of the
match rate may comprise related individuals (eg, siblings),
which could inﬂate the overall URD 8/8 match rate. This
would only inﬂate the match rate when a related donor was
the only match for that case. Care was taken to remove
suspected twin siblings or duplicate URD ﬁles in the NMDP
search results, when an URD had the same date of birth and
consistent HLA typing as the case PP.
The results of this study provide a baseline 8/8 and 10/10
HR match rate for patients seeking an URD that can be
further supplemented using the additional worldwide URD
inventory, including single HLA-mismatched URD and mis-
matched cord blood units when no full match is available.
This also provides important information for URD recruit-
ment and availability efforts and can be helpful in appreci-
ating the differences in success of locating 8/8 HR matches
for patients of different racial and ethnic backgrounds. This
can equip a transplantation team for the education of pa-
tients early in the process of an URD search.
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